A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe Biden on lowering prescription drug costs in posts online that suggest President Donald Trump has canceled the $35 insulin co-pay cap for certain Medicare programs.

Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose levels in real-time in non-diabetics.

has announced that the US Food and Drug Administration (FDA) has cleared Tidepool Loop, an automated insulin dosing app intended for the management of type 1 diabetes (T1D) in those six years old ...

“Rescinding the cap on insulin at $35 only makes pharmaceutical richer and everyday Americans, including MAGA voters, seriously poorer,” Steven Bechloss—author of the Substack, America, America — posted to the Bluesky social media platform.

This article highlights recent developments in healthcare, including the U.S. FDA's approval of Alzheimer's and diabetes drugs, challenges facing the World Health Organization after funding cuts, lawsuits regarding insulin prices,

It also caps insulin ... could impact drug prices by curbing research into cost-reduction models and suggests that reducing drug prices is not a priority for the Trump administration.

The final proposed model would have had Medicare pay less for drugs that receive accelerated approvals from the Food and Drug Administration (FDA ... such as the $35 per month cap on insulin costs, were not affected by Trump’s executive order.

Shares in the Irvine-based medical device company rose 29% to $23.64 and a $975 million market within the first three hours of trading.

The company estimates that its install base surpassed 15,000 by the end of last year, leading to sales of more than $20 million in the fourth quarter.

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, not just the glucose impact of individual meals, they’ve been designed, largely thanks to Knudsen’s work, with slight changes to allow them to hang out in the blood longer than GLP-1 normally does.

While some studies suggest probiotics may help you lose weight and belly fat, more research is needed on their effectiveness. Here are the strains to try.

The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies show it lowers kidney-related complications by 24 per cent. This offers new hope for patients,